Skip to main content

Value Base Ltd.

SEC CIK
0001992355
Latest filing
Jul 29, 2026

The latest 13F from Value Base Ltd. covers Q2 2026 (filed Jul 29, 2026): 6 long positions worth $162.3M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Cognyte Software Ltd. (CGNT) at 34.9%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
2
Est. +$1.91M
Reduced
0
Sold out
1
Est. −$152.8K

Top 5 holdings

Share of this quarter's portfolio value

  1. CGNTCognyte Software Ltd.
    34.9%$56.7MHistory
  2. VLNValens Semiconductor Ltd.
    29.9%$48.6MHistory
  3. AUDCAudiocodes Ltd
    15.7%$25.4MHistory
  4. PERIPerion Network Ltd.
    9.3%$15.1MHistory
  5. RDCMRadcom Ltd
    7.5%$12.2MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. CGNTCognyte Software Ltd.
    +$1.88MAddedHistory
  2. VLNValens Semiconductor Ltd.
    +$26.6KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. VLNValens Semiconductor Ltd.
    +10.79 pp19.1% → 29.9%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. DRTSWAlpha Tau Medical Ltd.
    −$152.8KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. DRTSWAlpha Tau Medical Ltd.
    −0.12 pp0.1% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$162.3M
+$35.5M (+28.0%) vs. prior quarter
Positions
6
−1 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.1%
Q2 2026, one quarter
Average holding period
6.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $175.0M (Q2 2025)

Q4 2024: $163.3MQ1 2025: $152.9MQ2 2025: $175.0MQ3 2025: $141.2MQ4 2025: $133.5MQ1 2026: $126.9MQ2 2026: $162.3M
Q4 2024Q2 2026
13F filings of Value Base Ltd. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 29, 20266$162.3MCGNTVLNAUDCvs. Q1 2026SEC
Q1 2026May 6, 20267$126.9MCGNTVLNAUDCvs. Q4 2025SEC
Q4 2025Feb 9, 20268$133.5MCGNTVLNAUDCvs. Q3 2025SEC
Q3 2025Oct 30, 20257$141.2MCGNTVLNAUDCvs. Q2 2025SEC
Q2 2025Jul 31, 20257$175.0MVLNCGNTPERIvs. Q1 2025SEC
Q1 2025May 8, 20258$152.9MCGNTVLNAUDCvs. Q4 2024SEC
Q4 2024Feb 11, 20258$163.3MVLNCGNTTEAD–SEC